Eagle Rock Energy Partners, L.P.
http://www.eaglerockenergy.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Eagle Rock Energy Partners, L.P.
Ferring Looks For Early Microbiome Wins, But Willing To Do Heavy Lifting
Switzerland’s Ferring is diving deep into the microbiome, looking at a range of potential therapy platforms including bacteriophage and probiotics. Its CSO believes a microbiome-based therapeutic approach could benefit dermatological and women’s health conditions, as well as gastro-intestinal disorders.
Hard-Core Computing To Drive Microbiome-based R&D
Israel’s RondinX is analyzing the microbiome with specific algorithms in order to develop new therapeutic approaches to disease.
Ferring To Pioneer Phage Therapies For Crohn’s Disease
The Switzerland-based company targets a novel therapeutic area still small enough for it to make a difference, the development of bacteriophage therapies for disorders thought to be associated with abnormal bacterial microflora, with proof-of-principle studies to begin later this year.
INTERVIEW: SillaJen CEO Confident On ‘Dream’ Cancer Therapy (Pt. 1)
After years of convincing the medical industry about the value of its novel cancer immunotherapy, South Korea’s SillaJen may be stepping closer to its goal of commercializing the “dream cancer therapy.” The bioventure’s CEO shared his views on the product and SillaJen’s future in the first part of this exclusive interview with PharmAsia News.
Company Information
- Other Names / Subsidiaries
-
- Crow Creek Energy
- CC Energy II LLC
- HESCO
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice